Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne K Vosburg

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Psychopharmacology|September 15, 2006
Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroinMaria A Sullivan, Suzanne K Vosburg, Sandra D Comer
Journal of Pain Research|March 20, 2026
Evaluation of Abuse Deterrent Formulations of Oxycodone Products: Real-World Data from an Enriched Population of Substance Users Assessed with the Addiction Severity Index-Multimedia Version (ASI-MV<sup>®</sup>)Jody L Green, Taryn Dailey-Govoni, Suzanne K Vosburg
Journal of Opioid Management|September 25, 2024
Opioid-related clinical outcomes and associated healthcare costs following abuse/misuse of oxycodone formulations: A HEOR analysis from real-world dataJody L Green, Taryn Dailey-Govoni, Suzanne K Vosburg
Journal of Opioid Management|February 11, 2012
Evaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidineSuzanne K Vosburg, Maria A Sullivan, Sandra D Comer
Journal of Opioid Management|March 3, 2026
Systematic review of real-world data associated with opioid scheduling and nonmedical useSuzanne K Vosburg, Taryn Dailey-Govoni, Jody L Green
Pain and Therapy|April 15, 2026
Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist MedicationsJody L Green, Taryn Dailey-Govoni, Suzanne K Vosburg
Pharmacoepidemiology and Drug Safety|June 28, 2017
Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring ProgramSuzanne K Vosburg, Colleen Haynes, Andrea Besharat, et al.
Drug and Alcohol Dependence|March 30, 2010
Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chanceSuzanne K Vosburg, Margaret Haney, Eric Rubin, et al.
Drug and Alcohol Dependence|July 9, 2005
An evaluation of the reinforcing effects of memantine in cocaine-dependent humansSuzanne K Vosburg, Carl L Hart, Margaret Haney, et al.
JAMA Network Open|February 16, 2026
Prevalence of Over-the-Counter and Prescription Medication Use in the USJody L Green, Taryn Dailey-Govoni, Sita D Kalidindi, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Psychopharmacology|September 15, 2006
Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroinMaria A Sullivan, Suzanne K Vosburg, Sandra D Comer
Journal of Pain Research|March 20, 2026
Evaluation of Abuse Deterrent Formulations of Oxycodone Products: Real-World Data from an Enriched Population of Substance Users Assessed with the Addiction Severity Index-Multimedia Version (ASI-MV<sup>®</sup>)Jody L Green, Taryn Dailey-Govoni, Suzanne K Vosburg
Journal of Opioid Management|September 25, 2024
Opioid-related clinical outcomes and associated healthcare costs following abuse/misuse of oxycodone formulations: A HEOR analysis from real-world dataJody L Green, Taryn Dailey-Govoni, Suzanne K Vosburg
Journal of Opioid Management|February 11, 2012
Evaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidineSuzanne K Vosburg, Maria A Sullivan, Sandra D Comer
Journal of Opioid Management|March 3, 2026
Systematic review of real-world data associated with opioid scheduling and nonmedical useSuzanne K Vosburg, Taryn Dailey-Govoni, Jody L Green
Pain and Therapy|April 15, 2026
Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist MedicationsJody L Green, Taryn Dailey-Govoni, Suzanne K Vosburg
Pharmacoepidemiology and Drug Safety|June 28, 2017
Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring ProgramSuzanne K Vosburg, Colleen Haynes, Andrea Besharat, et al.
Drug and Alcohol Dependence|March 30, 2010
Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chanceSuzanne K Vosburg, Margaret Haney, Eric Rubin, et al.
Drug and Alcohol Dependence|July 9, 2005
An evaluation of the reinforcing effects of memantine in cocaine-dependent humansSuzanne K Vosburg, Carl L Hart, Margaret Haney, et al.
JAMA Network Open|February 16, 2026
Prevalence of Over-the-Counter and Prescription Medication Use in the USJody L Green, Taryn Dailey-Govoni, Sita D Kalidindi, et al.
Pageof 7